CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Curis, Inc.
Curis, Inc.
AstraZeneca
Acerta Pharma BV
Center for International Blood and Marrow Transplant Research
Center for International Blood and Marrow Transplant Research